NEW YORK (AP) — Alimera Sciences and pSivida said Friday the FDA approved their eye disease implant Iluvien.
Iluvien is an implant delivered by injection that is intended to treat diabetic macular edema, a condition that can cause blurred vision and blindness. The implant is designed to gradually release tiny amounts of a corticosteroid medication for three years. Alimera Sciences plans to launch the drug ...
Also read: Trump and Pence hit new lows in Fox poll